Literature DB >> 10748949

Approach to the patient with a history of adverse reactions to aspirin or NSAIDs: diagnosis and treatment.

D D Stevenson1.   

Abstract

Aspirin and nonsteroidal antiinflammatory drugs can induce several different reactions. It is incumbant upon the astute physician to recognize the differences between these reactions, the clinical settings in which they occur, and the management of each type of reaction. In this article, I have attempted to clarify and simplify, as much as possible, the approach I take in addressing the problems of adverse reactions to these drugs. In addition, the problems of cross-reactions are explained in terms of COX-1 and 2 isoenzymes. Aspirin desensitization and treatment with daily ASA are also addressed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10748949     DOI: 10.2500/108854100778248944

Source DB:  PubMed          Journal:  Allergy Asthma Proc        ISSN: 1088-5412            Impact factor:   2.587


  5 in total

Review 1.  Cutaneous reactions to aspirin and nonsteroidal antiinflammatory drugs.

Authors:  Mario Sánchez-Borges; Arnaldo Capriles-Hulett; Fernan Caballero-Fonseca
Journal:  Clin Rev Allergy Immunol       Date:  2003-04       Impact factor: 8.667

2.  Diclofenac induces basophil degranulation without increasing CD63 expression in sensitive patients.

Authors:  A Malbrán; E Yeyati; G L Rey; N Galassi
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

Review 3.  Pathogenesis of aspirin-exacerbated respiratory disease.

Authors:  Donald D Stevenson; Bruce L Zuraw
Journal:  Clin Rev Allergy Immunol       Date:  2003-04       Impact factor: 8.667

Review 4.  Hypersensitivity to Aspirin and other NSAIDs: Diagnostic Approach in Patients with Chronic Rhinosinusitis.

Authors:  Joanna Makowska; Anna Lewandowska-Polak; Marek L Kowalski
Journal:  Curr Allergy Asthma Rep       Date:  2015-08       Impact factor: 4.806

Review 5.  The dichotomy of pathogens and allergens in vaccination approaches.

Authors:  Fiona J Baird; Andreas L Lopata
Journal:  Front Microbiol       Date:  2014-07-16       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.